Cargando…
Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet
The pathogenesis of non-alcoholic steatohepatitis (NASH) is still unclear and the prevention of the development of hepatocellular carcinoma (HCC) has not been established. We established an atherogenic and high-fat diet mouse model that develops hepatic steatosis, inflammation, fibrosis, and liver t...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522259/ https://www.ncbi.nlm.nih.gov/pubmed/28591717 http://dx.doi.org/10.18632/oncotarget.18116 |
_version_ | 1783252134844694528 |
---|---|
author | Okada, Hikari Takabatake, Riuta Honda, Masao Takegoshi, Kai Yamashita, Taro Nakamura, Mikiko Shirasaki, Takayoshi Sakai, Yoshio Shimakami, Tetsuro Nagata, Naoto Takamura, Toshinari Tanaka, Takuji Kaneko, Shuichi |
author_facet | Okada, Hikari Takabatake, Riuta Honda, Masao Takegoshi, Kai Yamashita, Taro Nakamura, Mikiko Shirasaki, Takayoshi Sakai, Yoshio Shimakami, Tetsuro Nagata, Naoto Takamura, Toshinari Tanaka, Takuji Kaneko, Shuichi |
author_sort | Okada, Hikari |
collection | PubMed |
description | The pathogenesis of non-alcoholic steatohepatitis (NASH) is still unclear and the prevention of the development of hepatocellular carcinoma (HCC) has not been established. We established an atherogenic and high-fat diet mouse model that develops hepatic steatosis, inflammation, fibrosis, and liver tumors at a high frequency. Using two NASH-HCC mouse models, we showed that peretinoin, an acyclic retinoid, significantly improved liver histology and reduced the incidence of liver tumors. Interestingly, we found that peretinoin induced autophagy in the liver of mice, which was characterized by the increased co-localized expression of microtubule-associated protein light chain 3B-II and lysosome-associated membrane protein 2, and increased autophagosome formation and autophagy flux in the liver. These findings were confirmed using primary mouse hepatocytes. Among representative autophagy pathways, the autophagy related (Atg) 5-Atg12-Atg16L1 pathway was impaired; especially, Atg16L1 was repressed at both the mRNA and protein level. Decreased Atg16L1 mRNA expression was also found in the liver of patients with NASH according to disease progression. Promoter analysis revealed that peretinoin activated the promoter of Atg16L1 by increasing the expression of CCAAT/enhancer-binding-protein-alpha. Interestingly, Atg16L1 overexpression in HepG2 cells inhibited palmitate-induced NF-kB activation and interleukin-6-induced STAT3 activation. We showed that Atg16L1 induced the de-phosphorylation of Gp130, a receptor subunit of interleukin-6 family cytokines, which subsequently repressed phosphorylated-STAT3 (Tyr705) levels, and this process might be independent of autophagy function. Thus, peretinoin prevents the progression of NASH and the development of HCC through activating the autophagy pathway by increased Atg16L1 expression, which is an essential regulator of autophagy and anti-inflammatory proteins. |
format | Online Article Text |
id | pubmed-5522259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-55222592017-08-21 Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet Okada, Hikari Takabatake, Riuta Honda, Masao Takegoshi, Kai Yamashita, Taro Nakamura, Mikiko Shirasaki, Takayoshi Sakai, Yoshio Shimakami, Tetsuro Nagata, Naoto Takamura, Toshinari Tanaka, Takuji Kaneko, Shuichi Oncotarget Priority Research Paper The pathogenesis of non-alcoholic steatohepatitis (NASH) is still unclear and the prevention of the development of hepatocellular carcinoma (HCC) has not been established. We established an atherogenic and high-fat diet mouse model that develops hepatic steatosis, inflammation, fibrosis, and liver tumors at a high frequency. Using two NASH-HCC mouse models, we showed that peretinoin, an acyclic retinoid, significantly improved liver histology and reduced the incidence of liver tumors. Interestingly, we found that peretinoin induced autophagy in the liver of mice, which was characterized by the increased co-localized expression of microtubule-associated protein light chain 3B-II and lysosome-associated membrane protein 2, and increased autophagosome formation and autophagy flux in the liver. These findings were confirmed using primary mouse hepatocytes. Among representative autophagy pathways, the autophagy related (Atg) 5-Atg12-Atg16L1 pathway was impaired; especially, Atg16L1 was repressed at both the mRNA and protein level. Decreased Atg16L1 mRNA expression was also found in the liver of patients with NASH according to disease progression. Promoter analysis revealed that peretinoin activated the promoter of Atg16L1 by increasing the expression of CCAAT/enhancer-binding-protein-alpha. Interestingly, Atg16L1 overexpression in HepG2 cells inhibited palmitate-induced NF-kB activation and interleukin-6-induced STAT3 activation. We showed that Atg16L1 induced the de-phosphorylation of Gp130, a receptor subunit of interleukin-6 family cytokines, which subsequently repressed phosphorylated-STAT3 (Tyr705) levels, and this process might be independent of autophagy function. Thus, peretinoin prevents the progression of NASH and the development of HCC through activating the autophagy pathway by increased Atg16L1 expression, which is an essential regulator of autophagy and anti-inflammatory proteins. Impact Journals LLC 2017-05-23 /pmc/articles/PMC5522259/ /pubmed/28591717 http://dx.doi.org/10.18632/oncotarget.18116 Text en Copyright: © 2017 Okada et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Priority Research Paper Okada, Hikari Takabatake, Riuta Honda, Masao Takegoshi, Kai Yamashita, Taro Nakamura, Mikiko Shirasaki, Takayoshi Sakai, Yoshio Shimakami, Tetsuro Nagata, Naoto Takamura, Toshinari Tanaka, Takuji Kaneko, Shuichi Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet |
title | Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet |
title_full | Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet |
title_fullStr | Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet |
title_full_unstemmed | Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet |
title_short | Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet |
title_sort | peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet |
topic | Priority Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522259/ https://www.ncbi.nlm.nih.gov/pubmed/28591717 http://dx.doi.org/10.18632/oncotarget.18116 |
work_keys_str_mv | AT okadahikari peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet AT takabatakeriuta peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet AT hondamasao peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet AT takegoshikai peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet AT yamashitataro peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet AT nakamuramikiko peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet AT shirasakitakayoshi peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet AT sakaiyoshio peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet AT shimakamitetsuro peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet AT nagatanaoto peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet AT takamuratoshinari peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet AT tanakatakuji peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet AT kanekoshuichi peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet |